These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37424827)

  • 1. Galectin-8 alters immune microenvironment and promotes tumor progression.
    Wang Y; Sun Y; Li H; Xu J
    Am J Cancer Res; 2023; 13(6):2517-2529. PubMed ID: 37424827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
    Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment.
    Farhad M; Rolig AS; Redmond WL
    Oncoimmunology; 2018; 7(6):e1434467. PubMed ID: 29872573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target.
    Zhang M; Liu C; Li Y; Li H; Zhang W; Liu J; Wang L; Sun C
    Front Cell Dev Biol; 2023; 11():1332205. PubMed ID: 38264357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
    Yin J; Li L; Wang C; Zhang Y
    Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
    Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
    Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.
    Trebo A; Ditsch N; Kuhn C; Heidegger HH; Zeder-Goess C; Kolben T; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Hester A
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
    Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
    Front Immunol; 2020; 11():1820. PubMed ID: 33013832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient's Clinical Outcome in Triple-Negative Breast Cancer.
    Ju MH; Byun KD; Park EH; Lee JH; Han SH
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer.
    Chen P; Zhang L; Zhang W; Sun C; Wu C; He Y; Zhou C
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
    PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1 expression is associated with tumour immunity and prognosis in gingival squamous cell carcinoma.
    Noda Y; Kishino M; Sato S; Hirose K; Sakai M; Fukuda Y; Murakami S; Toyosawa S
    J Clin Pathol; 2017 Feb; 70(2):126-133. PubMed ID: 28108653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive pulmonary disease severity: An observational study.
    Brajer-Luftmann B; Kaczmarek M; Nowicka A; Stelmach-Mardas M; Wyrzykiewicz M; Yasar S; Piorunek T; Sikora J; Batura-Gabryel H
    Medicine (Baltimore); 2022 Jun; 101(23):e29208. PubMed ID: 35687771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity.
    Sturgill ER; Rolig AS; Linch SN; Mick C; Kasiewicz MJ; Sun Z; Traber PG; Shlevin H; Redmond WL
    Oncoimmunology; 2021 Mar; 10(1):1892265. PubMed ID: 33717655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.
    Corapi E; Carrizo G; Compagno D; Laderach D
    Front Immunol; 2018; 9():2190. PubMed ID: 30319642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of genes related to innate antifungal immunity in the absence of galectin-3.
    Rezende CP; Martins Oliveira Brito PK; Pessoni AM; Da Silva TA; Goldman GH; Almeida F
    Virulence; 2021 Dec; 12(1):981-988. PubMed ID: 33779504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases.
    Coppock JD; Mills AM; Stelow EB
    Head Neck Pathol; 2021 Mar; 15(1):163-168. PubMed ID: 32564273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.